Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Sanara MedTech (SMTI) Cost of Revenue (2016 - 2025)

Historic Cost of Revenue for Sanara MedTech (SMTI) over the last 15 years, with Q3 2025 value amounting to $1.9 million.

  • Sanara MedTech's Cost of Revenue fell 591.23% to $1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.9 million, marking a year-over-year increase of 282.29%. This contributed to the annual value of $8.1 million for FY2024, which is 365.75% up from last year.
  • Per Sanara MedTech's latest filing, its Cost of Revenue stood at $1.9 million for Q3 2025, which was down 591.23% from $1.9 million recorded in Q2 2025.
  • Over the past 5 years, Sanara MedTech's Cost of Revenue peaked at $2.4 million during Q4 2022, and registered a low of $474433.0 during Q1 2021.
  • Over the past 5 years, Sanara MedTech's median Cost of Revenue value was $1.9 million (recorded in 2025), while the average stood at $1.6 million.
  • As far as peak fluctuations go, Sanara MedTech's Cost of Revenue soared by 33054.75% in 2022, and later crashed by 2452.22% in 2023.
  • Sanara MedTech's Cost of Revenue (Quarter) stood at $782772.0 in 2021, then surged by 202.66% to $2.4 million in 2022, then decreased by 24.52% to $1.8 million in 2023, then increased by 25.78% to $2.2 million in 2024, then dropped by 16.67% to $1.9 million in 2025.
  • Its last three reported values are $1.9 million in Q3 2025, $1.9 million for Q2 2025, and $1.8 million during Q1 2025.